Exploring Indonesia’s Pharmaceutical Market: Facilitating Indonesia–Japan Business Collaboration
Connecting Japanese and Indonesian Pharmaceutical Businesses On 5–6 August 2026, SAN Consulting supported and facilitated business meetings involving Komeda Pharmaceutical Co., Ltd. of Japan, Apotek K-24 Indonesia, and PT Bernofarm. The engagement was also accompanied and supported by JETRO Japan and BNI Japan Desk, bringing together stakeholders from the business, trade-support, and financial ecosystems. The meetings formed part of Komeda Pharmaceutical’s exploration of opportunities within the Indonesia pharmaceutical market.
Rather than focusing on a predetermined transaction, the discussions provided an opportunity for the parties to exchange perspectives on the Indonesian market, potential cooperation models, distribution possibilities, and regulatory considerations.
For an international company evaluating Indonesia, these early discussions can play an important role in understanding whether market opportunities align with the company’s products, capabilities, and longer-term business objectives. Exploring Business Models, Distribution, and Regulation During the meetings, the parties discussed several areas relevant to a potential pharmaceutical market entry in Indonesia.
One key topic was how a Japanese pharmaceutical company could approach the Indonesian market through an appropriate local business and distribution structure.
For many foreign companies, selecting a market-entry model involves multiple considerations. A company may need to assess potential distributors, understand how products reach customers, evaluate potential commercial partners, and determine the regulatory requirements applicable to its products and planned activities.
The discussions therefore covered potential business and partnership models, possible distribution approaches, the role of Indonesian partners, and relevant pharmaceutical regulatory considerations.
Komeda Pharmaceutical expressed interest in further understanding opportunities in Indonesia, particularly the possibility of approaching the market through suitable distribution partnerships while developing a clearer understanding of the applicable regulatory environment.
The meetings remained exploratory, with the objective of building mutual understanding and identifying areas that may warrant further evaluation.
Introduction
Connecting Japanese and Indonesian Pharmaceutical Businesses On 5–6 August 2026, SAN Consulting supported and facilitated business meetings involving Komeda Pharmaceutical Co., Ltd. of Japan, Apotek K-24 Indonesia, and PT Bernofarm. The engagement was also accompanied and supported by JETRO Japan and BNI Japan Desk, bringing together stakeholders from the business, trade-support, and financial ecosystems. The meetings formed part of Komeda Pharmaceutical’s exploration of opportunities within the Indonesia pharmaceutical market.
Rather than focusing on a predetermined transaction, the discussions provided an opportunity for the parties to exchange perspectives on the Indonesian market, potential cooperation models, distribution possibilities, and regulatory considerations.
For an international company evaluating Indonesia, these early discussions can play an important role in understanding whether market opportunities align with the company’s products, capabilities, and longer-term business objectives. Exploring Business Models, Distribution, and Regulation During the meetings, the parties discussed several areas relevant to a potential pharmaceutical market entry in Indonesia.
One key topic was how a Japanese pharmaceutical company could approach the Indonesian market through an appropriate local business and distribution structure.
For many foreign companies, selecting a market-entry model involves multiple considerations. A company may need to assess potential distributors, understand how products reach customers, evaluate potential commercial partners, and determine the regulatory requirements applicable to its products and planned activities.
The discussions therefore covered potential business and partnership models, possible distribution approaches, the role of Indonesian partners, and relevant pharmaceutical regulatory considerations.
Komeda Pharmaceutical expressed interest in further understanding opportunities in Indonesia, particularly the possibility of approaching the market through suitable distribution partnerships while developing a clearer understanding of the applicable regulatory environment.
The meetings remained exploratory, with the objective of building mutual understanding and identifying areas that may warrant further evaluation.
Content
From Market Interest to Market Entry
Interest in Indonesia does not automatically translate into a viable market-entry strategy.
International companies considering doing business in Indonesia generally need to answer several interconnected questions: Is there sufficient market potential?
Market size alone is not always enough. Companies need to understand customer segments, competitive dynamics, pricing, demand characteristics, and whether their products or capabilities address an identifiable market need.
What is the appropriate market-entry model?
Depending on the sector and business objective, market entry may involve a distributor, local commercial partner, strategic cooperation, direct investment, or another structure.
Who is the right local partner?
A potential partner should not be assessed only based on company size or reputation. Distribution capabilities, customer access, geographic coverage, regulatory capabilities, strategic alignment, and operational readiness may all be relevant.
What regulatory requirements apply?
Regulatory considerations can materially influence how a company structures its entry into Indonesia, particularly in regulated industries such as pharmaceuticals and healthcare.
What happens after the initial introduction?
Successful market development usually requires additional commercial validation, partner discussions, regulatory assessment, negotiation, and execution planning.
These questions illustrate why business matching in Indonesia should involve more than arranging meetings.
An introduction becomes more valuable when the companies involved are selected based on a clear understanding of the foreign company’s objectives, intended market position, potential entry model, and requirements for a local partner.
For this reason, partner identification should ideally be integrated into the broader market-entry process. Business Matching as Part of Market-Entry Strategy A distributor search in Indonesia or local partner search in Indonesia often starts with creating a list of potential companies.
However, the number of companies identified is less important than their relevance.
Before approaching potential partners, international companies should clarify what role they expect a local organization to perform.
For example, a company seeking market access may prioritize an established distribution network. Another may require regulatory capabilities, specific customer relationships, technical expertise, or experience working with international companies.
Understanding these requirements allows business matching to become a strategic exercise rather than simply a networking activity.
The August discussions involving Komeda Pharmaceutical, Apotek K-24 Indonesia, and PT Bernofarm reflect this approach: bringing relevant organizations into direct dialogue so that potential market opportunities, partnership structures, and practical market-entry considerations can be explored.
Let's Work together
Supporting International Companies Entering Indonesia SAN Consulting supports international companies across different stages of their Indonesia market entry journey.
Depending on the company's objectives and stage of market development, this may include:
• Market Research & Opportunity Assessment
Understanding market characteristics, industry structure, potential demand, competitors, and relevant commercial considerations before committing resources to the market.
• Market Entry Strategy
Evaluating potential entry approaches and developing a practical pathway based on the company’s objectives, capabilities, and Indonesian market conditions.
• Partner & Distributor Search
Identifying potential Indonesian distributors, business partners, customers, or strategic stakeholders based on defined selection criteria.
• Business Matching & Meeting Arrangement
Approaching relevant organizations and facilitating discussions between international companies and potential Indonesian counterparts.
• Regulatory Understanding
Helping companies identify relevant regulatory considerations and determine areas requiring further regulatory assessment or specialist support.
• Local Business Development
Supporting follow-up discussions and market-development activities as companies progress from initial exploration toward more concrete business opportunities.
—
For cross-border engagements, SAN Consulting also acts as a business bridge between international companies and Indonesian stakeholders, helping both sides establish a clearer understanding of business objectives, market expectations, and potential areas of cooperation.
The engagement on 5–6 August demonstrates how Indonesia market entry consulting can combine market understanding, stakeholder identification, business matching, and regulatory considerations within the same market-development process. — Turning Indonesia Market Potential into Action
Indonesia can represent an attractive growth market for international companies, but understanding the opportunity is only the first step.
Companies must determine how they should enter, which organizations they should engage with, what regulatory requirements need to be addressed, and what practical actions should follow.
This is particularly important in sectors such as pharmaceuticals, where commercial strategy, distribution capabilities, local partnerships, and regulatory requirements are closely interconnected.
For Japanese and other international companies exploring Indonesia, having access to relevant local stakeholders can help transform initial market interest into more informed business decisions.
SAN Consulting works with international companies evaluating market-entry and business-expansion opportunities in Indonesia.
—
If your company is considering Indonesia and needs support with market research, market-entry strategy, partner or distributor identification, business matching, regulatory considerations, or local business development, contact SAN Consulting to discuss your market-entry objectives.